Terms: = Breast cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Clinical Outcome
19 results:
1. Identification of FOXE3 transcription factor as a potent oncogenic factor in triple-negative breast cancer.
Wang H; Yang T; Yuan Y; Sun X
Biochem Biophys Res Commun; 2020 Feb; 523(1):78-85. PubMed ID: 31831170
[TBL] [Abstract] [Full Text] [Related]
2. FoxO3a Mediates the Inhibitory Effects of the Antiepileptic Drug Lamotrigine on breast cancer Growth.
Pellegrino M; Rizza P; Nigro A; Ceraldi R; Ricci E; Perrotta I; Aquila S; Lanzino M; Andò S; Morelli C; Sisci D
Mol Cancer Res; 2018 Jun; 16(6):923-934. PubMed ID: 29523760
[TBL] [Abstract] [Full Text] [Related]
3. Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27kip1.
Liu H; Qiu H; Song Y; Liu Y; Wang H; Lu M; Deng M; Gu Y; Yin J; Luo K; Zhang Z; Jia X; Zheng G; He Z
Oncogene; 2017 Apr; 36(14):1952-1964. PubMed ID: 27694903
[TBL] [Abstract] [Full Text] [Related]
4. A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing breast cancer.
Menyhárt O; Santarpia L; Győrffy B
Curr Cancer Drug Targets; 2015; 15(8):665-83. PubMed ID: 26452383
[TBL] [Abstract] [Full Text] [Related]
5. p27(kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysis.
Guan X; Wang Y; Xie R; Chen L; Bai J; Lu J; Kuo MT
J Cell Mol Med; 2010 Apr; 14(4):944-53. PubMed ID: 19298520
[TBL] [Abstract] [Full Text] [Related]
6. Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer.
Davidovich S; Ben-Izhak O; Shapira M; Futerman B; Hershko DD
Breast Cancer Res; 2008; 10(4):R63. PubMed ID: 18644126
[TBL] [Abstract] [Full Text] [Related]
7. Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.
Zhang W; Bergamaschi D; Jin B; Lu X
Blood; 2005 May; 105(9):3691-8. PubMed ID: 15665120
[TBL] [Abstract] [Full Text] [Related]
8. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract] [Full Text] [Related]
9. High p27kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.
Pohl G; Rudas M; Dietze O; Lax S; Markis E; Pirker R; Zielinski CC; Hausmaninger H; Kubista E; Samonigg H; Jakesz R; Filipits M
J Clin Oncol; 2003 Oct; 21(19):3594-600. PubMed ID: 14512390
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27kip1 expression on tissue microarrays of node negative breast cancer.
Han S; Park K; Bae BN; Kim KH; Kim HJ; Kim YD; Kim HY
J Surg Oncol; 2003 Aug; 83(4):241-7. PubMed ID: 12884237
[TBL] [Abstract] [Full Text] [Related]
11. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(kip1).
Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
[TBL] [Abstract] [Full Text] [Related]
12. Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy.
Pohl G; Rudas M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Filipits M
Breast Cancer Res Treat; 2003 Mar; 78(1):97-103. PubMed ID: 12611462
[TBL] [Abstract] [Full Text] [Related]
13. Biomarker prediction of clinical outcome in operable breast cancer patients treated with tamoxifen.
Scarpi E; De Paola F; Sarti M; Bajorko P; Granato AM; Volpi A; Nanni O; Maltoni R; Amadori D
Breast Cancer Res Treat; 2001 Jul; 68(2):101-10. PubMed ID: 11688513
[TBL] [Abstract] [Full Text] [Related]
14. p27kip1 expression and survival in NO gastric carcinoma.
Migaldi M; Zunarelli E; Sgambato A; Leocata P; Ventura L; De Gaetani C
Pathol Res Pract; 2001; 197(4):231-6. PubMed ID: 11358008
[TBL] [Abstract] [Full Text] [Related]
15. Correlation of p27 protein expression with HER-2/neu expression in breast cancer.
Newman L; Xia W; Yang HY; Sahin A; Bondy M; Lukmanji F; Hung MC; Lee MH
Mol Carcinog; 2001 Mar; 30(3):169-75. PubMed ID: 11301477
[TBL] [Abstract] [Full Text] [Related]
16. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27.
Yang HY; Zhou BP; Hung MC; Lee MH
J Biol Chem; 2000 Aug; 275(32):24735-9. PubMed ID: 10859299
[TBL] [Abstract] [Full Text] [Related]
18. Reduced expression of p27kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation.
Han S; Park K; Kim HY; Lee MS; Kim HJ; Kim YD
Breast Cancer Res Treat; 1999 May; 55(2):161-7. PubMed ID: 10481943
[TBL] [Abstract] [Full Text] [Related]
19. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
[TBL] [Abstract] [Full Text] [Related]
